{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/04/3338085/0/en/CervoMed-Announces-Neflamapimod-Awarded-Innovation-Passport-Designation-Under-the-UK-Innovative-Licensing-and-Access-Pathway-ILAP-for-Treatment-of-Dementia-with-Lewy-Bodies-DLB.html", "message": "News view counter 865391 successfully enlarged"}